Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene Gel for Plantar Warts
NCT04823845Phase 1Withdrawn
- Sponsor
- University of Louisville
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of adapalene in plantar wart, sponsored by University of Louisville. Primary endpoint: Time Until Plantar Wart Resolution. Planned start May 2022; status: withdrawn.
02
Drugs
adapalene
03
Conditions
plantar wart
Beyond the preview
Go deeper on NCT04823845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04823845.